文献速递糖尿病肥胖与代谢综合征

全科医生强化治疗培训对血糖正常「高危」人群死亡率与心血管疾病发病率是否有溢出效应?ADDITION-Denmark 整群随机对照试验结果

Does training of general practitioners for intensive treatment of people with screen-detected diabetes have a spillover effect on mortality and cardiovascular morbidity in 'at risk' individuals with normoglycaemia? Results from the ADDITION-Denmark cluster-randomised controlled trial.
PubMed 文献 · Diabetologia · 2017-03-09

在 ADDITION-Denmark 整群随机试验中,175 家全科诊所被随机分为常规照护组与强化治疗培训组,次级分析纳入 2001 至 2006 年间糖尿病风险问卷阳性但生化检测血糖正常的 21,513 人。中位随访 8.9 年,强化治疗组首次心血管疾病事件发生率低于常规照护组(HR 0.92 [95%CI 0.85, 0.99]),心血管疾病风险最高者(心脏 SCORE ≥10)关联更强(HR 0.85 [95%CI 0.75, 0.96]),两组全因死亡率无差异(HR 1.02 [95%CI 0.92, 1.14])。

要点

  • 强化治疗培训组血糖正常高危人群首次心血管疾病事件发生率低于常规照护组,HR 0.92(95%CI 0.85, 0.99)。
  • 心脏 SCORE ≥10 者中关联更强,HR 0.85(95%CI 0.75, 0.96)。
  • 两组全因死亡率无差异,HR 1.02(95%CI 0.92, 1.14)。

核心结论

  • 全科医生接受目标导向的血糖及其他心血管危险因素强化管理培训,对糖尿病高危但血糖正常人群的心血管疾病风险显示出一定溢出效应,该效应在心血管疾病风险最高者中尤为明显,对死亡率无影响。

研究设计与样本

  • ADDITION-Denmark 整群随机对照试验的次级分析,175 家全科诊所被整群随机分为筛查加常规照护组与筛查加强化多因素治疗培训与支持组。
  • 纳入 2001 至 2006 年间糖尿病风险问卷阳性但生化检测血糖正常的 21,513 人,其中常规照护组 10,289 人、强化治疗组 11,224 人。
  • 中位随访 8.9 年,利用国家登记数据比较两组首次心血管疾病事件与全因死亡率。

主要发现

  • 随访 9 年期间共发生 3784 例首次心血管疾病事件和 1748 例死亡。
  • 强化治疗组首次心血管疾病事件发生率低于常规照护组,HR 0.92(95%CI 0.85, 0.99)。
  • 心血管疾病风险最高者(心脏 SCORE ≥10)中关联更强,HR 0.85(95%CI 0.75, 0.96)。
  • 两组全因死亡率无差异,HR 1.02(95%CI 0.92, 1.14)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Within a trial of intensive treatment of people with screen-detected diabetes, we aimed to assess a potential spillover effect of the trial intervention on incident cardiovascular disease (CVD) and all-cause mortality among people who screened positive on a diabetes risk questionnaire but who were normoglycaemic. METHODS: In the Anglo-Danish-Dutch Study of Intensive Treatment In People with Screen-Detected Diabetes in Primary Care (ADDITION)-Denmark trial, 175 general practices were cluster-randomised into: (1) screening plus routine care of individuals with screen-detected diabetes (control group); or (2) screening plus training and support in intensive multifactorial treatment of individuals with screen-detected diabetes (intervention group). We identified all individuals who screened positive on a diabetes risk questionnaire in ADDITION-Denmark but were normoglycaemic following biochemical testing for use in this secondary analysis. After a median 8.9 years follow-up, we used data from national registers to compare rates of first CVD events and all-cause mortality in individuals in the routine care group with those in the intensive treatment group. RESULTS: In total, 21,513 individuals screened positive for high risk of diabetes but were normoglycaemic on biochemical testing in ADDITION-Denmark practices between 2001 and 2006 (10,289 in the routine care group and 11,224 in the intensive treatment group). During 9 years of follow-up, there were 3784 first CVD events and 1748 deaths. The incidence of CVD was lower among the intensive treatment group compared with the routine care group (HR 0.92 [95% CI 0.85, 0.99]). This association was stronger among individuals at highest CVD risk (heart SCORE ≥ 10; HR 0.85 [95% CI 0.75, 0.96]). There was no difference in mortality between the two treatment groups (HR 1.02 [95% CI 0.92, 1.14]). CONCLUSIONS/INTERPRETATION: Training of general practitioners to provide target-driven intensive management of blood glucose levels and other cardiovascular risk factors showed some evidence of a spillover effect on the risk of CVD over a 9 year period among individuals at high risk of diabetes. The effect was particularly pronounced among those at highest risk of CVD. There was no effect on mortality. TRIAL REGISTRATION: ClinicalTrials.gov NCT00237549.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Simmons RK, Bruun NH, Witte DR, et al. Does training of general practitioners for intensive treatment of people with screen-detected diabetes have a spillover effect on mortality and cardiovascular morbidity in 'at risk' individuals with normoglycaemia? Results from the ADDITION-Denmark cluster-randomised controlled trial. Diabetologia. 2017. PMID: 28280901. doi:10.1007/s00125-017-4230-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。